[Use of Raveron in adenomectomies].
The loss of blood during adenectomies was quantitatively measured in 25 prostatic patients with or without Raveron-premediaction. The result in the 11 patients pretreated with Raveron was in comparison to the 14 untreated patients a reduction to one half of the blood lost by gram of the tumour tissue removed. Furthermore we observed a better demarcation of the tumour-tissue and operability together with a postoperative recovery without complications in patients treated with Raveron.
D002277:Carcinoma / Q000601:surgery; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D011292:Premedication; D011467:Prostate; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D011471:Prostatic Neoplasms / Q000601:surgery; D014020:Tissue Extracts / Q000008:administration & dosage*
D014020:Tissue Extracts
Die Anwendung von Raveron bei Adenomektomien.